Major breakthrough could help detect multiple sclerosis 10 years earlier

Date:

Share this article:

Del denne artikel:

New research suggests early warning signs of multiple sclerosis may be hiding in the bloodstream years before symptoms appear.

Most people assume serious neurological diseases appear without warning. In reality, many conditions develop quietly for years before they are discovered. Researchers now believe multiple sclerosis (MS) may leave detectable traces in the body long before a diagnosis is made.

According to researchers at McGill University in Canada, whose findings were published in Annals of Neurology, specific blood proteins could help identify people at higher risk of developing MS more than ten years before symptoms emerge, reports Knowridge.

Hidden signals

Multiple sclerosis is a disease in which the immune system attacks the protective layer surrounding nerve fibers in the brain and spinal cord. Over time, this can affect movement, vision, balance, and memory.

Because symptoms often appear gradually, many patients are diagnosed only after damage has already occurred. Scientists have therefore been searching for biological markers that could reveal the disease much earlier.

Also read: Early signs of cancer you should take seriously

To investigate, the research team analyzed more than 2,500 blood proteins and identified dozens linked to future MS risk.

A decade earlier

The findings were then tested using data from the UK Biobank, which has followed around 500,000 participants for years.

Among people who later developed MS, researchers found eight proteins that showed measurable changes before diagnosis. Some of these differences were present more than a decade earlier.

One protein, known as DKKL1, attracted particular attention because it was associated with both a lower risk of MS and a potentially milder disease course.

Also read: A daily glass of juice or a smoothie linked to lower depression levels

What happens next?

The researchers believe blood-based screening tools could eventually help doctors identify high-risk individuals before symptoms begin.

While further studies are needed, the results offer hope that earlier monitoring and treatment may one day reduce the long-term impact of multiple sclerosis.

Also read: Gut microbiota in infancy may be linked to the development of autism and ADHD

This article is made and published by Mie Hermansen, who may have used AI in the preparation.

Other articles

Millions may lose GLP-1 drug coverage as employers and insurers cut benefits

The bill for weight-loss drugs like Wegovy is landing on patients as major insurers pull back.

How eating meat every day may affect your heart

Meat is a common source of protein, iron, and vitamin B12, but not all types of meat have...

Nearly 1 in 6 children on weight loss drugs developed a nutritional deficiency within a year

A new US study of more than 2,000 children on GLP-1 medications found that 16.8 percent developed a nutritional deficiency within twelve months, and vitamin D led the list.

7 supplements to avoid if you take an SSRI

About 1 in 9 US adults now takes a prescription antidepressant, and pairing one with the wrong supplement can push brain serotonin to dangerous levels.

Millions may lose GLP-1 drug coverage as employers and insurers cut benefits

The bill for weight-loss drugs like Wegovy is landing on patients as major insurers pull back.

How eating meat every day may affect your heart

Meat is a common source of protein, iron, and vitamin B12, but not all types of meat have...

Nearly 1 in 6 children on weight loss drugs developed a nutritional deficiency within a year

A new US study of more than 2,000 children on GLP-1 medications found that 16.8 percent developed a nutritional deficiency within twelve months, and vitamin D led the list.